All participants are invited to submit abstracts on one of the topics listed below for presentation at the 19th ECCMID.

 

Abstracts may only be submitted via internet at this website. Late abstracts will not be considered.
In order to standardize the abstract layout we ask you to read the preparation guidelines at this link CAREFULLY! Avoid submission within 48 hours of the deadline for best system performance.

 

 

Guidelines for submission of abstracts:

1. Abstracts may be submitted only via internet. Abstracts submitted via fax or email will not be accepted.
2. All abstracts must be submitted and presented in English using UK English spelling.
3. Abstracts must contain original material neither published nor presented elsewhere prior to 16 May 2009.
4. Please structure your abstract using the following headings:
   
   • Objectives
   • Methods
   • Results
   • Conclusion
5. The abstract text may not be longer than 2’500 characters, including spaces. Tables, charts and other graphics are permitted and must be in JPG or GIF format and of high resolution – a separate upload button is provided (max. 1 graphic per abstract)
6. Avoid complex mathematical formulae. For the symbols ≤ or ≥ type instead <= or >=. For superscript use caret (^) e.g. 10^6 instead of 10⁶. Do not use Greek letters and symbols. Instead of ‘IFN- γ’ use for example ‘IFN-g’ or ‘IFN-gamma’.
7. Spelling Guidelines: The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full on first mention and then abbreviated on subsequent mention.
   The following general rules apply (Examples in parentheses):
   
   • Systematic names (genus, family and higher orders): capitalized
     (Chlamydia, Enterobacteriaceae, Picornaviridae). Italicizing will be done by the editors.
   • Non-systematic names (e.g. plural): lower case (Group A streptococci, mycobacteria, chlamydiae)
   • Generic drug names: lower case (penicillin)
   • Brand names: capitalized with trademark symbol (Rocephin®)
   • Diseases and viruses: lower case (hepatitis, herpes zoster, herpesvirus, West Nile virus)
   • Please observe standard English grammar rules including a space after full stops and commas.
   • Only common abbreviations approved for use by CMI can be used without definition. For details consult the ESCMID website at www.escmid.org, Clinical Microbiology & Infection, Guidelines for Authors.
8. Authors should indicate their presentation preference:
   • poster only
   • oral or poster presentation
9. Authors are asked to enter 3 keywords to better define the abstract content.
10. After having submitted your abstract, you will receive a confirmation by email with your personal access codes (please make sure to state your correct email address!). Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access codes. Corrections to abstracts can only be made up to the deadline of 7 January 2009. If you do not receive a confirmation by email please contact the abstract hotline.
11. Abstracts will be subject to a blind peer review by at least 3 members of the Programme Committee and external experts.
12. Authors will be notified of acceptance at the end of February 2009 by email.
13. Abstract authors must register for the conference by 10 March 2009 or advise us of withdrawal by this date. Registration ensures publication. Authors with accepted abstracts are entitled to the early registration fee if registered before 10 March 2009.
14. If an abstract is accepted, the presenting author must attend the congress and present it in person. If a presenting author withdraws an abstract after 10 March 2009 or does not attend the session for which he or she has been scheduled, a penalty will incur prohibiting the author from presenting papers at the ECCMID meetings for a period of 3 years. Those subject to this penalty will be informed in writing.
15. Click here to down load a pdf file giving further data entry tips and recommendations for submitting your abstract.

 

If you have difficulties in submitting your abstracts or if you need any further information, please contact the Abstract hotline: Phone +41 61 686 77 22 (Monday – Friday during CET business hours)

 

Topics

 

Please carefully select the topic under which you wish to submit your abstract for review. Abstracts not submitted under an appropriate topic may be incorrectly reviewed and rejected.

 

Basic science

1. Pathogenesis
2. Animal models including experimental treatment
3. Biofilm

 

Antimicrobials

4. Antimicrobial pharmacokinetics, pharmacodynamics and general pharmacology
5. Mechanisms of action and resistance
6. Resistance surveillance
7. Surveys of molecular epidemiology of resistance and resistance genes, strains or serotypes
8. In vitro antibacterial susceptibility and drug interaction studies
9. New antimicrobials
10. Epidemiology of MRSA, VRE and other Gram-positives
11. Epidemiology of MDR-Gram-negatives
12. Antibiotic usage

 

Molecular biology, including diagnostics

13. Molecular bacteriology
14. Molecular virology
15. Molecular typing
16. Molecular biology, including diagnostics – others

 

Diagnostics

17. Diagnostic/laboratory methods (other than molecular)
18. Methods for antibacterial susceptibility testing

 

Public Health

19. Public health and community-acquired infections
20. Emerging infectious diseases

 

Infection Control

21. Infection control
22. Clinical epidemiology of nosocomial infections (POWI, VAP, UTI, BSI, ...)

 

Travel medicine, tropical diseases and parasitology

23. Travelmedicine, tropical and parasitic diseases

 

Mycology

24. Resistance and mechanisms of action of antifungals
25. Fungal infections

 

Virology

26. AIDS and HIV infection
27. Hepatitis
28. Virology non-HIV/non-hepatitis

 

Clinical ID

29. Mycobacterial infections (including diagnosis)
30. Infection in the immunocompromised host and transplant recipients
31. Community-acquired infections including CAP, sepsis, STD, ...
32. Lyme borreliosis, toxoplasmosis
33. Antimicrobial clinical trials
34. Paediatric infections

 

Vaccines

35. Immunology, host defenses, immunotherapy
36. Vaccines

 

Internet

37. Internet and electronic resources

 

Publication

All accepted abstracts will be published as an electronic supplement to Clinical Microbiology and Infection (CMI), the official journal of ESCMID. All accepted abstracts will be made available to the participants on CD-ROM and on the 19th ECCMID website only. No abstract bookwill be printed, however a second CD containing most of the full posters will be produced. Please take advantage of the online meeting planner facility available before the congress. To this end, full abstract texts will be viewable on the 19th ECCMID website 10 days prior to the congress.

Presentation Format

Accepted abstracts are to be presented either as a poster or oral presentation. Additional abstracts may be accepted for inclusion in the “publication only” section of the Abstract CD. The final decision of the presentation format will be made by the Programme Committee. Full instructions concerning the preparation and presentation will be given in the acceptance email to be sent out at the end of February 2009.

 

 

Abstract submission has been closed